Published 6 February 2009, doi:10.1136/bmj.b458
Cite this as: BMJ 2009;338:b458

News

Appeals court rules that Nigerian families can sue Pfizer in US

Jeanne Lenzer

1 New York

The first 150 words of the full text of this article appear below.

A US federal appellate court has ruled that 88 Nigerian families can continue their lawsuit in the United States against Pfizer, the world’s largest drug maker. The 2-1 decision, issued by the Second Circuit Court in New York on 30 January, will allow the plaintiffs to reinstate their suit claiming that Pfizer conducted an illegal drug trial in 1996 during an outbreak of bacterial meningitis in Kano state, Nigeria.

The families allege that Pfizer conducted the study of its experimental drug trovafloxacin (Trovan) without obtaining informed consent (BMJ 2006;332:1233, doi:10.1136/bmj.332.7552.1233-a). According to court documents, the families claim that Pfizer gave the experimental drug to half of the 200 children enrolled in the study despite the results of animal studies showing that the drug had life threatening complications. Trovafloxacin never received approval for use in children in the US, and the European Union banned the drug in 1999.

. . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

In brief
BMJ 2009 338: b2147. [Extract] [Full Text]

Secret report surfaces showing that Pfizer was at fault in Nigerian drug tests
Jeanne Lenzer
BMJ 2006 332: 1233. [Extract] [Full Text] [PDF]

Access jobs at BMJ Careers
Whats new online at Student BMJ